Pacira BioSciences Inc logo

Pacira BioSciences Inc

$ 53.19 -1.05 (-1.94%) 10:08 PM EST
P/E:
64.87
P/B:
3.22
Market Cap:
$ 2.44B
Enterprise V:
$ 2.95B
Volume:
406.45K
Avg Vol (2M):
350.44K
Also Trade In:
Volume:
406.45K
Market Cap $:
2.44B
PE Ratio:
64.87
Avg Vol (2-Month):
350.44K
Enterprise Value $:
2.95B
PB Ratio:
3.22
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
Name Current Vs Industry Vs History
Cash-To-Debt 0.38
Equity-to-Asset 0.44
Debt-to-Equity 1.1
Debt-to-EBITDA 5.92
Interest Coverage 3.34
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.16
Distress
Grey
Safe
Beneish M-Score -1.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.9
9-Day RSI 42.52
14-Day RSI 43.69
6-1 Month Momentum % -31.24
12-1 Month Momentum % -6.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.95
Quick Ratio 3.2
Cash Ratio 2.38
Days Inventory 198.15
Days Sales Outstanding 47.28
Days Payable 27.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8

Financials (Next Earnings Date:2022-11-03 Est.)

PCRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PCRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 614.318
EPS (TTM) ($) 0.82
Beta 0.98
Volatility % 30.92
14-Day RSI 43.69
14-Day ATR ($) 1.899762
20-Day SMA ($) 54.0995
12-1 Month Momentum % -6.29
52-Week Range ($) 45.05 - 82.16
Shares Outstanding (Mil) 45.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pacira BioSciences Inc Filings

Document Form Filing Date
No Filing Data

Pacira BioSciences Inc Analysis

Share your research

Headlines

See More
No news.